Polatuzumab manuscript published on ejHaem

News, Newsletter February 26, 2024

Congratulations to Dr Briony Shaw, Ms Eliza Chung and other investigators who utilised LaRDR data to analyse outcomes of relapsed/ refractory…

7000th patient recruitment

News, Newsletter January 17, 2024

Congratulations to all participating sites at the Lymphoma and Related Diseases Registry (LaRDR) for enrolling the 7000th patient on January 4, 2024. We would like…

December 2023 newsletter is here.

New Sites, News, Newsletter December 1, 2023

Click here to read our December newsletter. Leave us a message if you would like to join the subscription list for future…

Thank you for attending the Hybrid Lymphoma Breakfast Meeting 2023!

Investigator Meeting, News, Newsletter November 21, 2023

The Lymphoma Breakfast Meeting co-hosted by the Australasian Lymphoma Alliance, Lymphoma and Related Diseases Registry, and Lymphoma Australia was a…

LaRDR at BLOOD Conference 2023!

News, Newsletter November 21, 2023

LaRDR showcased our research output in BLOOD in a poster presentation. Ms Eliza Chung presented the analysis of polatuzumab in relapsed…

ASH abstracts 2023

News, Newsletter November 1, 2023

The HoLISTIC Consortium which LaRDR participates and contributes data has two posters on the Identification of Risk Categories from the Advanced-Stage…

Welcome to new NZ site!

New Sites, News, Newsletter October 31, 2023

Christchurch Hospital came on board today after successfully obtaining site authorisation. Dr Emma-Jane McDonald will lead the team at CCH to facilitate patient recruitment….